Management of head and neck paragangliomas: Review of 120 patients
- 13 February 2009
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 31 (3), 381-387
- https://doi.org/10.1002/hed.20967
Abstract
Background. Head and neck paragangliomas (PGL) are rare, mostly benign tumors. About 10% to 15% of PGL are caused by mutations in the succinate dehydrogenase genes B, C, or D and may appear multifocally. Methods and Results. A retrospective review of 120 patients with 146 head and neck PGL, including 46 carotid body tumors (CBT), 13 vagal tumors, 55 jugulotympanic tumors (JTT), 25 tympanic tumors (TT) and 7 tumors in other locations are included. The internal carotid artery was preserved in 97.5% of CBT resections. Preservation of hearing was achieved in 92% of JTT and 88% of TT resections. Conclusion. According to our experience, the treatment of PGL must be individualized, taking into account the patient's age, medical condition, tumor site and size, multiple occurrences, and preexisting cranial nerve deficits. Tumor control is high whether treatment is by surgery or radiotherapy. Patients with solitary lesions whose disease is potentially resectable with acceptable morbidity are better treated surgically. © 2008 Wiley Periodicals, Inc. Head Neck, 2009Keywords
This publication has 42 references indexed in Scilit:
- 18F-DOPA positron emission tomography for the detection of glomus tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Familial Malignant Catecholamine-Secreting Paraganglioma with Prolonged Survival Associated with Mutation in the Succinate Dehydrogenase B GeneJournal of Clinical Endocrinology & Metabolism, 2002
- Hereditary paraganglioma targets diverse paragangliaJournal of Medical Genetics, 2002
- National Cancer Data Base report on malignant paragangliomas of the head and neckCancer, 2002
- Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial ParagangliomaAmerican Journal of Human Genetics, 2001
- Mutations in SDHC cause autosomal dominant paraganglioma, type 3Nature Genetics, 2000
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000
- Malignant Glomus TumorsThe Laryngoscope, 1999
- Vagal ParagangliomaJAMA Otolaryngology–Head & Neck Surgery, 1998
- Glomus Jugulare TumorsAnnals of Otology, Rhinology & Laryngology, 1974